ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma.

Although not statistically significant except two, a clear trend was observed that the MES-related gene signatures (MES subtype and EMT gene sets) are enriched in patients with low SH3GL3 or DNM3 expression levels (Supplementary Fig. 8c, d ).

also in 19,460 other papers